{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T23:50:08Z","timestamp":1773791408302,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1016\/j.metabol.2005.02.005","type":"journal-article","created":{"date-parts":[[2005,6,20]],"date-time":"2005-06-20T16:04:21Z","timestamp":1119283461000},"page":"910-917","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Inverse effects of the PPAR\u03b32 Pro12Ala polymorphism on measures of adiposity over 15 years in African Americans and whites. The CARDIA study"],"prefix":"10.1016","volume":"54","author":[{"given":"Myriam","family":"Fornage","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"David R.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael W.","family":"Steffes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myron D.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Molly S.","family":"Bray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela J.","family":"Schreiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.metabol.2005.02.005_bib1","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s001250051268","article-title":"PPARgamma, the ultimate thrifty gene","volume":"42","author":"Auwerx","year":"1999","journal-title":"Diabetologia"},{"issue":"1-2","key":"10.1016\/j.metabol.2005.02.005_bib2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0014-5793(98)01273-3","article-title":"PPARgamma3 mRNA: a distinct PPARgamma mRNA subtype transcribed from an independent promoter","volume":"438","author":"Fajas","year":"1998","journal-title":"FEBS Lett"},{"issue":"2","key":"10.1016\/j.metabol.2005.02.005_bib3","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1006\/bbrc.1997.7798","article-title":"Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation","volume":"241","author":"Yen","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.metabol.2005.02.005_bib4","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/3099","article-title":"A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity","volume":"20","author":"Deeb","year":"1998","journal-title":"Nat Genet"},{"issue":"11","key":"10.1016\/j.metabol.2005.02.005_bib5","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.2337\/diabetes.47.11.1806","article-title":"Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-gamma2 gene with obesity in two Caucasian populations","volume":"47","author":"Beamer","year":"1998","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.metabol.2005.02.005_bib6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/sj.ijo.0801112","article-title":"Impact of the peroxisome proliferator activated receptor gamma2 Pro12Ala polymorphism on adiposity, lipids and non\u2013insulin-dependent diabetes mellitus","volume":"24","author":"Meirhaeghe","year":"2000","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"10","key":"10.1016\/j.metabol.2005.02.005_bib7","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1136\/jmg.40.10.773","article-title":"Effect of the peroxisome proliferator activated receptor-gamma gene Pro12Ala variant on body mass index: a meta-analysis","volume":"40","author":"Masud","year":"2003","journal-title":"J Med Genet"},{"issue":"4","key":"10.1016\/j.metabol.2005.02.005_bib8","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/sj.ijo.0801210","article-title":"The Pro12Ala variant of peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2) is associated with measures of obesity in Mexican Americans","volume":"24","author":"Cole","year":"2000","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"6","key":"10.1016\/j.metabol.2005.02.005_bib9","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s001250051225","article-title":"The PPARgamma2 amino acid polymorphism Pro 12 Ala is prevalent in offspring of Type II diabetic patients and is associated to increased insulin sensitivity in a subgroup of obese subjects","volume":"42","author":"Koch","year":"1999","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.metabol.2005.02.005_bib10","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1006\/bbrc.1998.9962","article-title":"Pro12Ala missense mutation of the peroxisome proliferator activated receptor gamma and diabetes mellitus","volume":"254","author":"Ringel","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.metabol.2005.02.005_bib11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1006\/bbrc.1998.9421","article-title":"Effect of the Pro12Ala variant of the human peroxisome proliferator-activated receptor gamma 2 gene on adiposity, fat distribution, and insulin sensitivity in Japanese men","volume":"251","author":"Mori","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"10.1016\/j.metabol.2005.02.005_bib12","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1007\/s001250051243","article-title":"Homozygosity of the Pro12Ala variant of the peroxisome proliferation-activated receptor-gamma2 (PPAR-gamma2): divergent modulating effects on body mass index in obese and lean Caucasian men","volume":"42","author":"Ek","year":"1999","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.metabol.2005.02.005_bib13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2156-3-21","article-title":"Haplotype analysis of the PPARgamma Pro12Ala and C1431T variants reveals opposing associations with body weight","volume":"3","author":"Doney","year":"2002","journal-title":"BMC Genet"},{"issue":"1","key":"10.1016\/j.metabol.2005.02.005_bib14","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1006\/bbrc.2000.2605","article-title":"The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes","volume":"271","author":"Hara","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"10.1016\/j.metabol.2005.02.005_bib15","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1007\/s001250100629","article-title":"Studies of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2) gene in relation to insulin sensitivity among glucose tolerant Caucasians","volume":"44","author":"Ek","year":"2001","journal-title":"Diabetologia"},{"issue":"10","key":"10.1016\/j.metabol.2005.02.005_bib16","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1055\/s-2007-978663","article-title":"The PPARgamma2 polymorphism pro12Ala is associated with better insulin sensitivity in the offspring of type 2 diabetic patients","volume":"32","author":"Jacob","year":"2000","journal-title":"Horm Metab Res"},{"issue":"11","key":"10.1016\/j.metabol.2005.02.005_bib17","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s001090100255","article-title":"Sibling-based association study of the PPARgamma2 Pro12Ala polymorphism and metabolic variables in Chinese and Japanese hypertension families: a SAPPHIRe study. Stanford Asian-Pacific Program in Hypertension and Insulin Resistance","volume":"79","author":"Chuang","year":"2001","journal-title":"J Mol Med"},{"issue":"4","key":"10.1016\/j.metabol.2005.02.005_bib18","doi-asserted-by":"crossref","first-page":"876","DOI":"10.2337\/diabetes.50.4.876","article-title":"Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 gene is associated with increased antilipolytic insulin sensitivity","volume":"50","author":"Stumvoll","year":"2001","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.metabol.2005.02.005_bib19","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/0895-4356(88)90080-7","article-title":"CARDIA: study design, recruitment, and some characteristics of the examined subjects","volume":"41","author":"Friedman","year":"1988","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.metabol.2005.02.005_bib20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1249\/00005768-199301000-00012","article-title":"A simultaneous evaluation of 10 commonly used physical activity questionnaires","volume":"25","author":"Jacobs","year":"1993","journal-title":"Med Sci Sports Exerc"},{"issue":"1","key":"10.1016\/j.metabol.2005.02.005_bib21","first-page":"15","article-title":"A study of the reliability and comparative validity of the cardia dietary history","volume":"4","author":"Liu","year":"1994","journal-title":"Ethn Dis"},{"key":"10.1016\/j.metabol.2005.02.005_bib22","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0076-6879(86)29064-3","article-title":"Enzymatic methods for quantification of lipoprotein lipids","volume":"129","author":"Warnick","year":"1986","journal-title":"Methods Enzymol"},{"issue":"7","key":"10.1016\/j.metabol.2005.02.005_bib23","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"issue":"19","key":"10.1016\/j.metabol.2005.02.005_bib24","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP)","volume":"285","year":"2001","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.metabol.2005.02.005_bib25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2307\/2531248","article-title":"Longitudinal data analysis for discrete and continuous outcomes","volume":"42","author":"Zeger","year":"1986","journal-title":"Biometrics"},{"issue":"2","key":"10.1016\/j.metabol.2005.02.005_bib26","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1034\/j.1399-0004.2003.00026.x","article-title":"The PPAR-gamma P12A polymorphism modulates the relationship between dietary fat intake and components of the metabolic syndrome: results from the Quebec Family Study","volume":"63","author":"Robitaille","year":"2003","journal-title":"Clin Genet"},{"issue":"3","key":"10.1016\/j.metabol.2005.02.005_bib27","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2337\/diabetes.50.3.686","article-title":"Evidence for gene-nutrient interaction at the PPARgamma locus","volume":"50","author":"Luan","year":"2001","journal-title":"Diabetes"},{"issue":"22","key":"10.1016\/j.metabol.2005.02.005_bib28","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1093\/hmg\/ddg318","article-title":"Interaction between a peroxisome proliferator-activated receptor gamma gene polymorphism and dietary fat intake in relation to body mass","volume":"12","author":"Memisoglu","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.metabol.2005.02.005_bib29","unstructured":"UW-FHCRC Variation Discovery Resource. http:\/\/pga.gs.washington.edu\/data\/pparg\/. In."},{"issue":"7","key":"10.1016\/j.metabol.2005.02.005_bib30","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s001250100558","article-title":"Effect of the Pro12Ala polymorphism of the PPAR-gamma2 gene on long-term weight change in Finnish non-diabetic subjects","volume":"44","author":"Lindi","year":"2001","journal-title":"Diabetologia"},{"issue":"9","key":"10.1016\/j.metabol.2005.02.005_bib31","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.2337\/diabetes.50.9.2172","article-title":"Genetic variation in the peroxisome proliferator-activated receptor-gamma2 gene (Pro12Ala) affects metabolic responses to weight loss and subsequent weight regain","volume":"50","author":"Nicklas","year":"2001","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.metabol.2005.02.005_bib32","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/79216","article-title":"The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes","volume":"26","author":"Altshuler","year":"2000","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.metabol.2005.02.005_bib33","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.2337\/diabetes.52.6.1568","article-title":"Pro12Ala of the peroxisome proliferator-activated receptor-gamma2 gene is associated with lower serum insulin levels in nonobese African Americans: the Atherosclerosis Risk in Communities Study","volume":"52","author":"Kao","year":"2003","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.metabol.2005.02.005_bib34","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.2337\/diabetes.52.5.1265","article-title":"The peroxisome proliferator-activated receptor-gamma2 gene polymorphism (Pro12Ala) beneficially influences insulin resistance and its tracking from childhood to adulthood: the Bogalusa Heart Study","volume":"52","author":"Li","year":"2003","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.metabol.2005.02.005_bib35","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1210\/jc.2002-011511","article-title":"Differential effects of adiposity on peroxisomal proliferator-activated receptor gamma1 and gamma2 messenger ribonucleic acid expression in human adipocytes","volume":"87","author":"Sewter","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.metabol.2005.02.005_bib36","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1172\/JCI119424","article-title":"Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids","volume":"99","author":"Vidal-Puig","year":"1997","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.metabol.2005.02.005_bib37","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.2337\/diabetes.51.8.2341","article-title":"The peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism","volume":"51","author":"Stumvoll","year":"2002","journal-title":"Diabetes"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049505000922?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049505000922?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T03:01:03Z","timestamp":1758423663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049505000922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S0026049505000922"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2005.02.005","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inverse effects of the PPAR\u03b32 Pro12Ala polymorphism on measures of adiposity over 15 years in African Americans and whites. The CARDIA study","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2005.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}